Biotechnology - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

1 to 25 of 2375 results

Celgene third-quarter results beat estimates; ups guidance

Celgene third-quarter results beat estimates; ups guidance

23-10-2014

US biotech major Celgene today reported better-than-expected financial results, with net product sales…

BiotechnologyCelgene Corp.Celgene Corp.FinancialUnited StatesUSA

Sutro Biopharma and Celgene expand accord; add buyout option

23-10-2014

Sutro Biopharma today announced it has entered into a strategic collaboration and option agreement with…

BiotechnologyCelgene Corp.LicensingMergers & AcquisitionsOncologySutro Biopharma

Discussion launched about the future of biosimilars in Italy

Discussion launched about the future of biosimilars in Italy

23-10-2014

Results from a survey of 470 European physicians conducted by the Alliance for Safe Biologic Medicines…

BiosimilarBiosimilarsBiotechnologyItalyRegulation

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

23-10-2014

The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniMarkets & MarketingPricingSovaldiUSA

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

23-10-2014

Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed…

BelgiumBiotechnologyBoardroomCardio3 BioSciencesCardio3 BioSciences

Biogen Idec third-qtr net rockets 76% but shares slump

Biogen Idec third-qtr net rockets 76% but shares slump

23-10-2014

US biotech firm Biogen Idec saw its share price plunge 7% to $303.51, after its posted third-quarter…

Biogen IdecBiotechnologyFinancialNeurologicalTecfideraUSA

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

22-10-2014

US health care giant Johnson & Johnson is to commit up to $200 million to accelerate and expand the production…

Antibiotics and Infectious diseasesBavarian NordicBiotechnologyEuropeJanssenResearch

aTyr Pharma appoints John McKew as vice president of research

aTyr Pharma appoints John McKew as vice president of research

22-10-2014

US rare disease company aTyr Pharma has named John McKew as vice president of research.

aTyrBiotechnologyBoardroomNational Institutes of HealthUSA

FDA advisory backs expanded use of Vertex’ CF drug

22-10-2014

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, as a US Food and Drug Administration…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

22-10-2014

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance…

BiotechnologyGastro-intestinalsImmune PharmaceuticalsIsraelResearchUSA

Amgen advised to consider ‘radical’ split by lead investor

Amgen advised to consider ‘radical’ split by lead investor

22-10-2014

One of Amgen’s largest shareholders has said the USA-based biotechnolgy comapny would be better off…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUK

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

22-10-2014

Clinical-stage oncology biotech company PhosImmune has entered into a license and collaboration agreement…

BiotechnologyLicensingOncologyPhosImmunePureMHCUSA

Kamada says study supports alpha-1 antitrypsin Glassia for type-1 diabetes

22-10-2014

Israeli biopharma company Kamada says that a comprehensive review of the data available in the literature…

BiotechnologyDiabetesGlassiaKamadaResearch

MorphoSys gets milestone from Novartis; acquires new technology

21-10-2014

German company MorphoSys says it has received a milestone payment from Novartis in connection with the…

BiotechnologyLanthio PharmalanthipeptideMergers & AcquisitionsMorphoSysNovartisOphthalmicsResearch

Actelion beats expectations as third-qtr net profit rockets 39%

Actelion beats expectations as third-qtr net profit rockets 39%

21-10-2014

Switzerland’s Actelion, Europe’s largest biotech company, this morning announced third-quarter 2014…

ActelionBiotechnologyFinancialOpsumitRespiratory and PulmonarySwitzerlandTracleer

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

21-10-2014

Specialty biopharma company Auxilium Pharmaceuticals has received approval from the US Food And Drug…

Anti-Arthritics/RheumaticsAuxilium PharmaceuticalsBiotechnologyRegulationUSAXiaflex

Eurofins Genomics extends genomic business into Austria and Czech Republic

Eurofins Genomics extends genomic business into Austria and Czech Republic

21-10-2014

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, and international market leader…

AustriaBiotechnologyEurofins GenomicsGeneticsMarkets & Marketing

NewLink Genetics out-licenses NLG919 to Genentech

NewLink Genetics out-licenses NLG919 to Genentech

20-10-2014

US biotech firm NewLink Genetics saw its share price rocket 21.2% in morning trading today, after it…

BiotechnologyGenentechGlobalLicensingNewLink GeneticsNLG919OncologyRoche

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

20-10-2014

Mapp Biopharma’s ZMapp Ebola therapy will enhance public understanding of the drug development process,…

Antibiotics and Infectious diseasesBiotechnologyMapp BiopharmaceuticalResearchUSAZMapp

Astellas and CoMentis to end Alzheimer’s collaboration

20-10-2014

Japanese drug major Astellas Pharma and US biotech firm CoMentis have said they will end their worldwide…

Astellas PharmaBiotechnologyCoMentisLicensingNeurologicalResearch

Eylea beats Avastin and Lucentis for visual acuity in DME patients

Eylea beats Avastin and Lucentis for visual acuity in DME patients

19-10-2014

US biotech firm Regeneron Pharmaceuticals and partner Germany’s Bayer saw their shares leap 8.5% to…

AvastinBayerBiotechnologyEyleaGenentechLucentisNovartisOphthalmicsRegeneron PharmaceuticalsResearchRoche

Amgen sues Sanofi and Regeneron over alleged patent infringement

19-10-2014

USA-based Amgen has filed a law suit in the US District Court of Delaware against French pharma major…

alirocumabAmgenBiotechnologyCardio-vascularevolocumabLegalPatentsRegeneron PharmaceuticalsSanofiUSA

Profectus BioSciences gets US government funding for Ebola vaccine development

17-10-2014

Under a one-year contract with US biotech firm Profectus BioSciences, the US Department of Health and…

Anti-viralsBiotechnologyFinancialProfectus BioSciencesResearchUSA

1 to 25 of 2375 results

Back to top